Skip to main content
Log in

Human ovarian tumour cells can bind hyaluronic acid via membrane CD44: a possible step in peritoneal metastasis

  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Our previous studies have suggested that the interaction between hyaluronic acid (HA) on peritoneal mesothelial cells and the membrane adhesion molecule, CD44, on ovarian tumour cells could be important in ovarian cancer metastasis. In order to study this further, adhesion of six ovarian tumour lines to HA coated on to a plastic surface was investigated. Four lines bound to the HA coat and two lines did not. The adhesive lines were those that expressed high amounts of CD44, but the degree of adhesion was not closely correlated with CD44 expression. The results suggested that different tumour lines had different affinities for HA. Treatment of the HA coat with hyaluronidase substantially reduced adhesion. Adhesion was also partially reduced if the tumour cells were preincubated with either soluble HA, or anti-CD44 antibodies directed against the HA binding region. An antibody against a non-HA binding region only slightly blocked adhesion at high antibody concentrations. Only the CD44H isoform was detected by immunoprecipitation on the tumour cells. These results suggest that ovarian tumour cells can attach to immobilised HA via CD44H on the cell membrane.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Surveys, Office of Population Censuses and Surveys, 1994. Cancer Statistics 1989, HMSO.

  2. Hoskins WJ, 1993, Surgical staging and cytoreductive surgery of epithelial ovarian cancer. Cancer, 71, 1534–40.

    Google Scholar 

  3. Fox H, 1990, Pathology of ovarian cancer. In: Shepherd J and Monaghan J, eds. Clinical Gynaecological Cancer. Oxford: Blackwell Scientific Publishers, pp. 188–217.

    Google Scholar 

  4. Lesley J, Hyman R, and Kinkade PW, 1993, CD44 and its interaction with extracellular matrix. Adv in Immunol, 54, 271–335.

    Google Scholar 

  5. Catterall JB, Gardner MJ and Turner GA, 1995, Hyaluronic acid, cell adhesion and metastasis. The Cancer J, 8, 320–4.

    Google Scholar 

  6. Guo YJ, Ma J, Wang JH, et al., 1994, Inhibition of human-melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody. Cancer Res, 54, 1561–5.

    Google Scholar 

  7. Sy MS, Guo YJ and Stamenkovic I, 1991, Distinct effects of two CD44 isoforms on tumor growth in vivo. J Exp Med, 174, 859–66.

    Google Scholar 

  8. Sy MS, Guo YJ and Stamenkovic I, 1992, Inhibition of tumor growth in vivo with a soluble CD44-immunoglobulin fusion protein. J Exp Med, 176, 623–7.

    Google Scholar 

  9. Sleeman J, Moll J, Sherman L, et al., 1995, The role of CD44 splice variants in human metastatic cancer. Ciba Foundation Symposium, 189, 142–56.

    Google Scholar 

  10. Knudson W, Biswas C and Toole BP, 1984, Interactions between human tumor cells and fibroblasts stimulate hyaluronate synthesis. Proc Natl Acad Sci, 81, 6767–71.

    Google Scholar 

  11. Toole BP, Biswas C and Gross J, 1979, Hyaluronate and invasiveness of the rabbit V2 carcinoma. Proc Natl Acad Sci, 76, 6299–303.

    Google Scholar 

  12. Turley EA, Austen K, Vandeligt K and Clarey C, 1991, Hyaluronan and cell-associated hyaluronan binding protein regulate the locomotion of ras-transformed cells. J Cell Biol, 112, 1041–7.

    Google Scholar 

  13. Rooney P, Kumar S, Pouting J and Wang M, 1995, The role of hyaluronan in tumour neovascularization. Int J Cancer, 60, 632–6.

    Google Scholar 

  14. Gardner MJ, Jones LMH, Catterall JB and Turner GA, 1995, Expression of cell adhesion molecules on ovarian tumour cell lines and mesothelial cells, in relation to ovarian cancer metastasis. Cancer Lett, 91, 229–34.

    Google Scholar 

  15. Jones LMH, Gardner JB, Catterall JB and Turner GA, 1995, Hyaluronic acid secreted by mesothelial cells: a natural barrier to ovarian cancer cell adhesion. Clin Exp Metastasis, 13, 373–80.

    Google Scholar 

  16. Hills CA, Kelland LR, Abel G, Sirachy J, Wilson AP and Harrap KR, 1989, Biological properties of ten human ovarian caricinoma cell lines: calibration in vitro against four platinium complexes. Br J Cancer, 59, 527–34.

    Google Scholar 

  17. Mobus V, Gerharz CD, Press V, et al., 1992, Morphological, immunological, histochemical and biochemical characterisation of 6 newly established human ovarian tumour carcinoma cell lines. Int J Cancer, 52, 76–84.

    Google Scholar 

  18. Catterall JB, Gardner MJ, Jones LMH and Turner GA, 1994, A precise, rapid and sensitive in vitro assay to measure the adhesion of ovarian tumour cells to peritoneal mesothelial cells. Cancer Lett, 87, 199–203.

    Google Scholar 

  19. Stern P, Gilbert P, Sternberg S, Thompson S, Chada K, 1984, A monoclonal antibody which detects a 125kD glycoprotein on embryonal carcinoma cells and is mitogenic for murine spleen cells. J Reprod Immunol, 6, 313–28.

    Google Scholar 

  20. Cannistra SA, Kansas GS, Niloff J, Defranzo B, Kim Y and Ottensmeier C, 1993, Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H. Cancer Res, 53, 3830–8.

    Google Scholar 

  21. Lee JH, Kang Y-S, Kim B-G, et al, 1995, Expression of the CD44 adhesion molecule in primary and metastatic gynecologic malignancies and their cell lines. Int J Gynecol Cancer, 5, 193–9.

    Google Scholar 

  22. Cannistra SA, Abu-Jawdeh G, Niloff J, et al., 1995, CD44 variant expression is a common feature of epithelial ovarian cancer: lack of association with standard prognostic factors. J Clin Oncol, 13, 1912–21.

    Google Scholar 

  23. Fox SB, Fawcett J, Jackson DG, et al., 1994, Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms. Cancer Res, 54, 4539–46.

    Google Scholar 

  24. Anstee DJ, Gardner B, Spring FA, et al., 1991, New monoclonal antibodies in CD44 and CD58: their use to quantify CD44 and CD58 on normal human erythrocytes and to compare the distribution of CD44 and CD58 in human tissues. Immunol, 74, 197–205.

    Google Scholar 

  25. Belitsos PC, Hildreth JEK and August JT, 1990, Homotypic cell aggregation induced by anti-CD44 (Pgp-1) monoclonal antibodies and related to CD44 (Pgp-1) expression. J Immunol, 144, 1661–70.

    Google Scholar 

  26. Culty M, Miyake K, Kincade PW, et al., 1990, The hyaluronan receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins. J Cell Biol, 111, 2765–74.

    Google Scholar 

  27. East JA, Mitchell SD and Hart IR, 1993, Expression and function of the CD44 glycoprotein in melanoma cell lines. Melanoma Res, 3, 341–6.

    Google Scholar 

  28. Bennett KL, Modrell B, Greenfield B, et al., 1995, Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons. J Cell Biol, 131, 1623–33.

    Google Scholar 

  29. Lesley J, English N, Perschl A, Gregoroff J and Hyman R, 1995, Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J Exp Med, 182, 431–7.

    Google Scholar 

  30. Katoh S, Zheng Z, Oritani K, Shimozato T and Kinkade PW, 1995, Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J Exp Med, 182, 419–29.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gardner, M.J., Catterall, J.B., Jones, L.M.H. et al. Human ovarian tumour cells can bind hyaluronic acid via membrane CD44: a possible step in peritoneal metastasis. Clin Exp Metast 14, 325–334 (1996). https://doi.org/10.1007/BF00123391

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00123391

Keywords

Navigation